- Patent Title: Treatment of peripheral neuropathy induced by cancer chemotherapy
-
Application No.: US16916182Application Date: 2020-06-30
-
Publication No.: US11234947B2Publication Date: 2022-02-01
- Inventor: Praveen Anand
- Applicant: IMPERIAL COLLEGE INNOVATIONS LIMITED
- Applicant Address: GB London
- Assignee: IMPERIAL COLLEGE INNOVATIONS LIMITED
- Current Assignee: IMPERIAL COLLEGE INNOVATIONS LIMITED
- Current Assignee Address: GB London
- Agency: Kilyk & Bowersox, P.L.L.C.
- Main IPC: A61K31/165
- IPC: A61K31/165 ; A61P25/02 ; A61K9/70 ; A61K9/00

Abstract:
Methods of treating peripheral neuropathy induced by cancer chemotherapy and/or of stimulating the regeneration of peripheral sensory nerve fibers, comprising administering topically to one or more areas of the skin capsaicin or a capsaicinoid or topical TRPV1 agonist, to a patient in need thereof, wherein the capsaicin or capsaicinoid or TRPV1 agonist is administered after the patient has received cancer chemotherapy, and wherein the patient is not currently receiving cancer chemotherapy. Related kits comprising capsaicin-containing cutaneous patches for use with said methods.
Public/Granted literature
- US20210401780A1 Treatment of Peripheral Neuropathy Induced by Cancer Chemotherapy Public/Granted day:2021-12-30
Information query